Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751607 · ClinicalTrials.gov registry record
Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)
A clinical trial, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- Completed
- Registry status
- 400
- Enrollment target
NCT01751607 is a clinical trial that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 400 participants.
The verdict
NCT01751607 has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
This prospective study aims to examine the association of specific genetic variants (single nucleotide polymorphisms) located on chromosome 1, 4 and 16, with presence of non-pulmonary vein triggers (NPVT) as well as ablation-outcome in AF patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01751607
The ClinicalTrials.gov registry entry for NCT01751607 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Cardiac Arrhythmia Research Foundation, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01751607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01751607 about?
NCT01751607 is a clinical study titled "Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)". This prospective study aims to examine the association of specific genetic variants (single nucleotide polymorphisms) located on chromosome 1, 4 and 16, with presence of non-pulmonary vein triggers (NPVT) as well as ablation-outcome in AF patients
What is the current status of trial NCT01751607?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2012-12. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT01751607?
This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.